Furthermore, V-125 has anti-inflammatory activity in the iNOS suppression assay at the nM level (Fig. 1), which correlates with efficacy for prevention in the A/J lung cancer model, and nM activity in a RXRα reporter assay30. This evidence concerns the gene RXRA and lung carcinoma.